Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06033859 · ClinicalTrials.gov registry record
Incidence of Bleeding on Probing as an Indicator of Peri-Implant Disease Progression
A clinical trial, sponsored by University of Pittsburgh.
- Active
- Registry status
- 164
- Enrollment target
NCT06033859: Active study, sponsored by University of Pittsburgh.
NCT06033859 is a clinical trial that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 164 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06033859 is active but no longer recruiting, sponsored by University of Pittsburgh.
- ACTIVE NOT RECRUITING
- Registry status
- 164 participants
- Enrollment target
Study Summary
The primary goal of the present prospective cohort study is to evaluate the effect of varying incidences of BOP at implant sites across 15 months of maintenance visits on the probability of peri-implant disease progression. Over 15 months, participants will attend 6 visits where clinical measurements and maintenance care will be performed every 3 months.
Primary Outcome
MBL will be calculated by measuring the difference in marginal bone level between the standardized periapical radiographs. Progression will have to exceed a threshold of 0.5mm to be considered.
Interventions
- DIAGNOSTIC_TEST Clinical measurements
- DIAGNOSTIC_TEST Radiographic measurement
- PROCEDURE Dental prophylaxis or maintenance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2023-09-11 |
| Est. Completion | 2027-12 |
What the registry record for NCT06033859 still lists
NCT06033859 is an observational study that tracks outcomes without assigning an intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Clinical measurements is the first listed.
NCT06033859 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06033859 about?
NCT06033859 is a clinical study titled "Incidence of Bleeding on Probing as an Indicator of Peri-Implant Disease Progression". The primary goal of the present prospective cohort study is to evaluate the effect of varying incidences of BOP at implant sites across 15 months of maintenance visits on the probability of peri-implant disease progression. Over 15 months, participants will attend 6 visits where clinical measurement...
What is the current status of trial NCT06033859?
This trial is currently active not recruiting. The enrollment target is 164 participants. The study started on 2023-09-11. Estimated completion is 2027-12.
What interventions are being tested in trial NCT06033859?
The interventions under investigation include: Clinical measurements (DIAGNOSTIC_TEST), Radiographic measurement (DIAGNOSTIC_TEST), Dental prophylaxis or maintenance (PROCEDURE).
Who is sponsoring clinical trial NCT06033859?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04891289 · 164 participants · Phase 2
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- NCT04893226 · 164 participants · NA
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
- NCT05270213 · 164 participants · Phase 1
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- NCT05543681 · 164 participants · Phase 2
Clinical Trial on Agitation in Alzheimer's Dementia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI